First phase 3 Covid-19 vaccine trail begins in U.S.

The first phase three clinical trial for a U.S. coronavirus vaccine is
getting underway.

It's being conducted by Moderna and the National Institutes of Health
with roughly 30,000 people expected to take part in the study.

U.S. correspondent William Denselow reports.

IN: "Earlier this month...
OUT: SOC
DUR:39 seconds

Generic: http://fsnradionews.com/feeds/0727Drug-wd-generic.mp3